{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:09:48Z","timestamp":1773306588987,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.biomaterials.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:46:23Z","timestamp":1463186783000},"page":"109-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects"],"prefix":"10.1016","volume":"99","author":[{"given":"Sindhu","family":"Thangavel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena Kishore","family":"Sakharkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2016.05.001_bib1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/diacare.27.7.1660","article-title":"The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in\u00a0vivo","volume":"27","author":"Bogacka","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.18388\/abp.2008_3203","article-title":"Pioglitazone, a PPAR-gamma ligand, exerts cytostatic\/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome","volume":"55","author":"Mrowka","year":"2008","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib3","doi-asserted-by":"crossref","first-page":"314974","DOI":"10.1155\/2008\/314974","article-title":"A\u00a0role for the PPAR\u03b3 in Cancer therapy","volume":"2008","author":"Campbell","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib4","doi-asserted-by":"crossref","first-page":"704165","DOI":"10.1155\/2008\/704165","article-title":"PPAR\u03b3 and apoptosis in Cancer","volume":"2008","author":"Elrod","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib5","first-page":"25","article-title":"Thiazolidinediones as anti-cancer agents","volume":"6","author":"Blanquicett","year":"2008","journal-title":"Cancer Ther."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib6","first-page":"305","article-title":"Thiazolidinediones and liver toxicity","volume":"27","author":"Scheen","year":"2001","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib7","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/dmd.109.031583","article-title":"Identification of novel metabolic pathways of pioglitazone in hepatocytes: N-glucuronidation of thiazolidinedione ring and sequential ring-opening pathway","volume":"38","author":"Uchiyama","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pds.1804","article-title":"Case series of liver failure associated with rosiglitazone and pioglitazone","volume":"18","author":"Floyd","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cardfail.2008.02.007","article-title":"Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction","volume":"14","author":"Giles","year":"2008","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib11","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib12","first-page":"3","article-title":"Role of pioglitazone with metformin or glimepiride on oxidative stress-induced nuclear damage and reproductive toxicity in diabetic rats","volume":"17","author":"Rabbani","year":"2010","journal-title":"Malays. J. Med. Sci. MJMS"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/em.20365","article-title":"Assessment of genotoxicity in rats treated with the antidiabetic agent, pioglitazone","volume":"49","author":"Bedir","year":"2008","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib14","first-page":"225","article-title":"Liver glutathione depletion induced by bromobenzene, iodobenzene, and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis","volume":"118","author":"Casini","year":"1985","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2012\/762825","article-title":"Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison","volume":"2012","author":"Fiaschi","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2015.04.025","article-title":"Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer","volume":"209","author":"Thangavel","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2013.08.011","article-title":"Redox nanoparticle therapeutics to cancer\u2013increase in therapeutic effect of doxorubicin, suppressing its adverse effect","volume":"172","author":"Yoshitomi","year":"2013","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","article-title":"The development of androgen-independent prostate cancer","volume":"1","author":"Feldman","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib20","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1021\/bc900214f","article-title":"pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances","volume":"20","author":"Yoshitomi","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/bm801278n","article-title":"Design of core\u2013shell-type nanoparticles carrying stable radicals in the core","volume":"10","author":"Yoshitomi","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2012\/593878","article-title":"Preparation of folate-conjugated pluronic F127\/Chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment","volume":"2012","author":"Manaspon","year":"2012","journal-title":"J.\u00a0Nanomater."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1078-0432.CCR-06-1839","article-title":"Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin","volume":"13","author":"Tamvakopoulos","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib24","first-page":"30","article-title":"Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry","author":"Sullards","year":"2001","journal-title":"Sci. STKE"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib25","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.3390\/molecules16119451","article-title":"Anti-inflammatory and free radial scavenging activities of the constituents isolated from Machilus zuihoensis","volume":"16","author":"Mao","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0003-2697(84)90084-8","article-title":"A\u00a0method to reduce interference by sucrose in the detection of thiobarbituric acid-reactive substances","volume":"137","author":"Shlafer","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib27","unstructured":"Thangavel S, Yoshitomi T, Sakharkar MK, Nagasaki Y. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer. Journal of Controlled Release."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-3659(97)00124-7","article-title":"Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours","volume":"51","author":"Kim","year":"1998","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib29","first-page":"6387","article-title":"A\u00a0new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib30","series-title":"Cancer Drug Resistance","first-page":"21","article-title":"Influence of tumor pH on therapeutic response","author":"Song","year":"2006"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib31","first-page":"1544","article-title":"Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines","volume":"150","author":"Theyer","year":"1993","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2015.04.025","article-title":"Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer","volume":"209","author":"Thangavel","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/JMN:26:1:027","article-title":"Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures","volume":"26","author":"Kratsovnik","year":"2005","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib34","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cyto.a.21068","article-title":"Quantifying nuclear p65 as a parameter for NF-\u03baB activation: correlation between ImageStream cytometry, microscopy and western blot","volume":"79","author":"Maguire","year":"2011","journal-title":"Cytometry Part A: J. Int. Soc. Anal. Cytol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)81476-2","article-title":"Reduced apoptosis and cytochrome c mediated caspase activation in mice lacking caspase 9","volume":"94","author":"Kuida","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib37","doi-asserted-by":"crossref","first-page":"31199","DOI":"10.1074\/jbc.C000405200","article-title":"Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1","volume":"275","author":"Jiang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4161\/cc.4.4.1583","article-title":"The PPAR-gamma agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines","volume":"4","author":"Radhakrishnan","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib39","first-page":"1891","article-title":"Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone","volume":"6","author":"Drobnjak","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib40","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1194\/jlr.M032375","article-title":"Acid ceramidase as a therapeutic target in metastatic prostate cancer","volume":"54","author":"Camacho","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.192.5.601","article-title":"Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death","volume":"192","author":"Strelow","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib42","first-page":"10","article-title":"Recovery of cognitive dysfunction via orally administered redox-polymer nanotherapeutics in SAMP8 mice","author":"Chonpathompikunlert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib43","first-page":"1","article-title":"Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis","volume":"28","author":"Eguchi","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib44","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1039\/C4TB00953C","article-title":"Biodistribution and clearance of aminoclay nanoparticles: implication for in\u00a0vivo applicability as a tailor-made drug delivery carrier","volume":"2","author":"Yang","year":"2014","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2016.05.001_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2982.2004.00633.x","article-title":"Mechanisms underlying duodeno-gastric reflux in man","volume":"17","author":"Koek","year":"2005","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/dmd.104.002683","article-title":"Metabolic activation of pioglitazone identified from rat and human liver microsomes and freshly isolated hepatocytes","volume":"33","author":"Baughman","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1470-2045(09)70064-6","article-title":"Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases","volume":"10","author":"Chun","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1096\/fj.02-0624com","article-title":"Recovery of hepatocellular ATP and \u201cpericentral apoptosis\u201d after hemorrhage and resuscitation","volume":"17","author":"Paxian","year":"2003","journal-title":"Faseb J."},{"key":"10.1016\/j.biomaterials.2016.05.001_bib49","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dcS13-2031","article-title":"Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013","volume":"36","author":"Schernthaner","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216301624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961216301624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:18:00Z","timestamp":1758903480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961216301624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":49,"alternative-id":["S0142961216301624"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.05.001","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}